Company: HURA
Filing Date: 2025-06-06
Form Type: 425
Source: 0001193125-25-137145
Chunk: 39

Company: TuHURA Biosciences, Inc./NV
Filing Date: 2025-06-06
Form: 425
Chunk 39
---
) and (iii), as would not, individually or in the aggregate, be reasonably expected to have a Material Adverse Effect.

3.7 . Assuming the accuracy of the representations and warranties of the Investors in Section 4, no consent, approval,
authorization, filing with or order of or registration with, any court or governmental agency or body is required in connection with the authorization, execution or delivery by the Company of the Transaction Agreements, the issuance and sale of the
Securities and the performance by the Company of its other obligations under the Transaction Agreements, except such as (a) have been or will be obtained or made under the Securities Act or the Exchange Act, (b) the filing of any requisite
notices and/or application(s) to the National Exchange for the issuance and sale of the Shares or Warrant Shares and the listing of the Shares or the Warrant Shares for trading or quotation, as the case may be, thereon in the time and manner
required thereby, (c) customary post-closing filings with the SEC or pursuant to state securities laws in connection with the offer and sale of the Shares or the Warrant Shares by the Company in the manner contemplated herein, which will be
filed on a timely basis, and (d) the filing of the registration statement required to be filed by this Agreement, (e) the receipt of Stockholder Approval, or (f) such that the failure of which to obtain would not have a Material
Adverse Effect. All notices, consents, authorizations, orders, filings and registrations which the Company is required to deliver or obtain prior to the Closing pursuant to the preceding sentence have been obtained or made or will be delivered or
obtained or effected, and shall remain in full force and effect, on or prior to the Closing. The Company is not, and never has been, an issuer identified in Rule 144(i)(1).

3.8 .

(a) The Company has filed all forms, statements, certifications, reports and documents required to be filed by it with the SEC under
Section 13, 14(a) and 15(d) of the Exchange Act for the one year preceding the date of this Agreement. As of the time it was filed with the SEC (or, if amended or superseded by a filing prior to the date of this Agreement, then on the date of
such filing), each of the filed SEC Reports complied in all material respects with the applicable requirements of the Exchange Act , and, as of the